SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-074175
Filing Date
2020-06-17
Accepted
2020-06-17 16:13:00
Documents
13
Period of Report
2020-06-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2022716d3_8k.htm   iXBRL 8-K 33718
2 EXHIBIT 99.1 tm2022716d3_ex99-1.htm EX-99.1 456846
  Complete submission text file 0001104659-20-074175.txt   796386

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA isee-20200617.xsd EX-101.SCH 3192
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE isee-20200617_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isee-20200617_pre.xml EX-101.PRE 22714
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2022716d3_8k_htm.xml XML 3604
Mailing Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119
Business Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 20969856
SIC: 2834 Pharmaceutical Preparations